鲁南制药两款产品获评第一批“沂蒙好货”品牌

Core Viewpoint - The announcement of the first batch of "Yimeng Good Goods" brands highlights the recognition of high-quality products in the region, with two products from Lunan Pharmaceutical Group being selected, showcasing the company's commitment to quality in the pharmaceutical sector [1][3]. Group 1: Product Recognition - Lunan Pharmaceutical Group's products, Xinkang Isosorbide Mononitrate Tablets and Qidali Jingfang Granules, have been successfully included in the "Yimeng Good Goods" brand list [1][3]. - The selection aims to strengthen industrial and regional brand development, establishing a reputable brand for Yimeng [3]. Group 2: Product Quality and Innovation - Qidali Jingfang Granules are based on a classic Ming Dynasty formula, with modern technological innovations ensuring high-quality raw materials and adherence to strict internal standards exceeding the Chinese Pharmacopoeia [4]. - Xinkang Isosorbide Mononitrate Tablets, a first-line treatment for coronary heart disease and angina, have achieved a raw material purity of 99.9%, surpassing standards set by the Chinese, American, and European Pharmacopoeias [4]. Group 3: Future Development - The company plans to leverage this recognition to enhance its brand influence, increase R&D investment, and improve product innovation capabilities [4]. - Lunan Pharmaceutical Group aims to continuously introduce high-quality and effective pharmaceutical products to contribute to public health and the high-quality development of the regional pharmaceutical industry [4].